Long-Term Efficacy and Safety Outcomes of Modified (Simplified) MVAC (Methotrexate/Vinblastine/Doxorubicin/Cisplatin) as Frontline Therapy for Unresectable or Metastatic Urothelial Cancer
Titel:
Long-Term Efficacy and Safety Outcomes of Modified (Simplified) MVAC (Methotrexate/Vinblastine/Doxorubicin/Cisplatin) as Frontline Therapy for Unresectable or Metastatic Urothelial Cancer
Auteur:
Necchi, Andrea Mariani, Luigi Giannatempo, Patrizia Raggi, Daniele Farè, Elena Nicolai, Nicola Piva, Luigi Biasoni, Davide Catanzaro, Mario Torelli, Tullio Stagni, Silvia Maffezzini, Massimo Pizzocaro, Giorgio De Braud, Filippo G. Gianni, Alessandro M. Salvioni, Roberto